Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours Β· Estimated delivery Aug 18 - Aug 23
At CHFA (Toronto, September 2025), the company positioned itself as a co-creation partner that can help brands deliver on both indulgence and functionality with the added benefit of deep sustainability roots at origin
Notably, blocking BV8 has been shown to sensitize previously resistant tumors to anti-PD1 therapy, converting them into PD1-responsive phenotypes [133]
Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation
P-21 (P021) a novel neurogenic peptide compound
US$ 20.17
US$ 23.73
US$ 21.49
US$ 28.53
US$ 25.10
US$ 27.72
